123 related articles for article (PubMed ID: 33134179)
41. Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer.
Vallius T; Hynninen J; Auranen A; Matomäki J; Oksa S; Roering P; Grènman S
Tumour Biol; 2017 Feb; 39(2):1010428317691189. PubMed ID: 28218038
[TBL] [Abstract][Full Text] [Related]
42. Value of detection of serum human epididymis secretory protein 4 and carbohydrate antigen 125 in diagnosis of early endometrial cancer of different pathological subtypes.
Liu X; Zhao F; Hu L; Sun Y
Onco Targets Ther; 2015; 8():1239-43. PubMed ID: 26060409
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses.
Dewan R; Dewan A; Jindal M; Bhardawaj M
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1103-1108. PubMed ID: 31030480
[TBL] [Abstract][Full Text] [Related]
44. Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer.
Lee S; Choi S; Lee Y; Chung D; Hong S; Park N
J Obstet Gynaecol Res; 2017 Jan; 43(1):220-227. PubMed ID: 27862665
[TBL] [Abstract][Full Text] [Related]
45. The prognostic and predictive value of combined HE4 and CA-125 in ovarian cancer patients.
Steffensen KD; Waldstrøm M; Brandslund I; Petzold M; Jakobsen A
Int J Gynecol Cancer; 2012 Nov; 22(9):1474-82. PubMed ID: 23095772
[TBL] [Abstract][Full Text] [Related]
46. Clinical Significance of CENP-H Expression in Uterine Cervical Cancer.
Weng MY; Li L; Hong SJ; Feng SY
Cancer Biol Med; 2012 Sep; 9(3):192-6. PubMed ID: 23691478
[TBL] [Abstract][Full Text] [Related]
47. Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study.
Capriglione S; Plotti F; Miranda A; Ricciardi R; Scaletta G; Aloisi A; Guzzo F; Montera R; Angioli R
Tumour Biol; 2015 Jun; 36(6):4151-6. PubMed ID: 25577252
[TBL] [Abstract][Full Text] [Related]
48. Value of serum marker HE4 in pulmonary carcinoma diagnosis.
Tang QF; Zhou ZW; Ji HB; Pan WH; Sun MZ
Int J Clin Exp Med; 2015; 8(10):19014-21. PubMed ID: 26770527
[TBL] [Abstract][Full Text] [Related]
49. Serum human epididymis secretory protein 4 as a potential biomarker of renal fibrosis in kidney transplantation recipients.
Luo J; Wang F; Wan J; Ye Z; Huang C; Cai Y; Liu M; Wu BQ; Li L
Clin Chim Acta; 2018 Aug; 483():216-221. PubMed ID: 29738696
[TBL] [Abstract][Full Text] [Related]
50. Elevated human epididymis protein 4 concentrations in chronic kidney disease.
Nagy B; Krasznai ZT; Balla H; Csobán M; Antal-Szalmás P; Hernádi Z; Kappelmayer J
Ann Clin Biochem; 2012 Jul; 49(Pt 4):377-80. PubMed ID: 22688735
[TBL] [Abstract][Full Text] [Related]
51. Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer.
Steffensen KD; Waldstrøm M; Brandslund I; Lund B; Sørensen SM; Petzold M; Jakobsen A
Oncol Lett; 2016 Jun; 11(6):3967-3974. PubMed ID: 27313725
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S
Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570
[TBL] [Abstract][Full Text] [Related]
53. HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure.
Piek A; Meijers WC; Schroten NF; Gansevoort RT; de Boer RA; Silljé HH
J Card Fail; 2017 Jan; 23(1):12-19. PubMed ID: 27224553
[TBL] [Abstract][Full Text] [Related]
54. The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay.
Yang J; Sa M; Huang M; Yang J; Xiang Z; Liu B; Tang A
Clin Biochem; 2013 Nov; 46(16-17):1705-8. PubMed ID: 24012857
[TBL] [Abstract][Full Text] [Related]
55. HE4 as a serum biomarker for ROMA prediction and prognosis of epithelial ovarian cancer.
Chen WT; Gao X; Han XD; Zheng H; Guo L; Lu RQ
Asian Pac J Cancer Prev; 2014; 15(1):101-5. PubMed ID: 24528007
[TBL] [Abstract][Full Text] [Related]
56. Increased HE4 mRNA Expression Correlates with High Level Of eIF3a mRNA And Better Survival in Women with Epithelial Ovarian Cancer.
Luo CH; Zhao M; Tang YX; Shahabi S; Fang KN; Chen Y; Tang Y; Chen XY; Wang J; Zhou HH
J Cancer; 2018; 9(6):1088-1095. PubMed ID: 29581788
[TBL] [Abstract][Full Text] [Related]
57. Serum human epididymis protein 4 (HE4) may be a better tumor marker in early lung cancer.
Zeng Q; Liu M; Zhou N; Liu L; Song X
Clin Chim Acta; 2016 Apr; 455():102-6. PubMed ID: 26851650
[TBL] [Abstract][Full Text] [Related]
58. Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?
Chudecka-Głaz A; Cymbaluk-Płoska A; Wężowska M; Menkiszak J
PLoS One; 2018; 13(3):e0194270. PubMed ID: 29584739
[TBL] [Abstract][Full Text] [Related]
59. Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer.
Zhu LC; Gao J; Hu ZH; Schwab CL; Zhuang HY; Tan MZ; Yan LM; Liu JJ; Zhang DY; Lin B
Am J Cancer Res; 2015; 5(2):830-43. PubMed ID: 25973320
[TBL] [Abstract][Full Text] [Related]
60. Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients.
Cymbaluk-Płoska A; Chudecka-Głaz A; Pius-Sadowska E; Sompolska-Rzechuła A; Machaliński B; Surowiec A; Menkiszak J
Onco Targets Ther; 2017; 10():3169-3175. PubMed ID: 28721066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
